Avalo Therapeutics Inc
(AVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -16,056 | -13,045 | N/A |
| Depreciation Amortization | 29 | 20 | N/A |
| Accounts payable and accrued liabilities | -708 | 818 | N/A |
| Other Working Capital | -2,650 | 765 | N/A |
| Other Operating Activity | 3,866 | -44 | 0 |
| Operating Cash Flow | $-15,518 | $-11,485 | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -20 | -29 | N/A |
| Investing Cash Flow | $-20 | $-29 | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Issued | 9,640 | N/A | N/A |
| Other Financing Activity | 14,219 | 5,416 | 0 |
| Financing Cash Flow | $23,859 | $5,416 | $N/A |
| Beginning Cash Position | 3,422 | 9,520 | N/A |
| End Cash Position | 11,742 | 3,422 | N/A |
| Net Cash Flow | $8,321 | $-6,098 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -15,518 | -11,485 | N/A |
| Capital Expenditure | -20 | -29 | N/A |
| Free Cash Flow | -15,538 | -11,514 | 0 |